Zhiming Huo

Maria Woodrow2
David J. M. Lewis2
Rafaela Giemza2
Eva Galiza1
2Maria Woodrow
2David J. M. Lewis
2Rafaela Giemza
1Eva Galiza
Learn More
  • David J. M. Lewis, Zhiming Huo, Susan Barnett, Ingrid Kromann, Rafaela Giemza, Eva Galiza +6 others
  • 2009
BACKGROUND An association was previously established between facial nerve paralysis (Bell's palsy) and intranasal administration of an inactivated influenza virosome vaccine containing an enzymatically active Escherichia coli Heat Labile Toxin (LT) adjuvant. The individual component(s) responsible for paralysis were not identified, and the vaccine was(More)
  • Zhiming Huo, Sara L. Bissett, Raphaela Giemza, Simon Beddows, Clarissa Oeser, David J. M. Lewis
  • 2012
UNLABELLED The sublingual route has been proposed as a needle-free option to induce systemic and mucosal immune protection against viral infections. In a translational study of systemic and mucosal humoral immune responses to sublingual or systemically administered viral antigens, eighteen healthy female volunteers aged 19-31 years received three(More)
  • Fernanda Schreiber, Zhiming Huo, Rafaela Giemza, Maria Woodrow, Nicola Fenner, Zoe Stevens +4 others
  • 2010
Bacille Calmette Guérin substrain Moreau Rio de Janeiro is an attenuated strain of Mycobacterium bovis that has been used extensively as an oral tuberculosis vaccine. We assessed its potential as a challenge model to study clinical and immunological events following repeated mycobacterial gut infection. Seven individuals received three oral challenges with(More)
  • 1